Clinical Trials Directory

Trials / Conditions / Stage III Adenoid Cystic Carcinoma of the Oral Cavity

Stage III Adenoid Cystic Carcinoma of the Oral Cavity

11 registered clinical trials studyying Stage III Adenoid Cystic Carcinoma of the Oral Cavity — 1 currently recruiting.

StatusTrialSponsorPhase
CompletedAcetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoi
NCT02123511
Mayo ClinicPhase 2
TerminatedTransoral Robotic Surgery in Treating Patients With Benign or Stage I-IV Head and Neck Cancer
NCT01254734
City of Hope Medical CenterN/A
TerminatedEsophagoscopy in Evaluating Treatment in Patients With Stage I-IV Head and Neck Cancer Who Are Undergoing Radi
NCT01164566
Wake Forest University Health SciencesN/A
CompletedL-lysine in Treating Oral Mucositis in Patients Undergoing Radiation Therapy With or Without Chemotherapy For
NCT01155609
University of WashingtonN/A
RecruitingTransoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
NCT01473784
Ohio State University Comprehensive Cancer CenterN/A
CompletedBevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Pri
NCT00492089
National Cancer Institute (NCI)Phase 2
CompletedErlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidne
NCT00101348
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedAlvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors
NCT00089362
National Cancer Institute (NCI)Phase 1
CompletedBortezomib Followed by the Addition of Doxorubicin at Disease Progression in Treating Patients With Locally Ad
NCT00077428
National Cancer Institute (NCI)Phase 2
CompletedBevacizumab, Fluorouracil, and Hydroxyurea Plus Radiation Therapy in Treating Patients With Advanced Head and
NCT00023959
National Cancer Institute (NCI)Phase 1
CompletedInterleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu
NCT00004074
National Cancer Institute (NCI)Phase 1